Detail Information of Post-Translational Modifications

General Information of Drug Transporter (DT)
DT ID	DTD0452 Transporter Info
Gene Name	SLC6A2
Transporter Name	Sodium-dependent noradrenaline transporter
Gene ID	6530
UniProt ID	P23975

Post-Translational Modification of This DT
Overview of SLC6A2 Modification Sites with Functional and Structural Information
Sequence	M L L A R M N P Q V Q P E N N G A D T G P E Q P L R A R K T A E L L V V K E R N G V Q C L L A P R D G D A Q P R E T W G K K I D F L L S V V G F A V D L A N V W R F P Y L C Y K N G G G A F L I P Y T L F L I I A G M P L F Y M E L A L G Q Y N R E G A A T V W K I C P F F K G V G Y A V I L I A L Y V G F Y Y N V I I A W S L Y Y L F S S F T L N L P W T D C G H T W N S P N C T D P K L L N G S V L G N H T K Y S K Y K F T P A A E F Y E R G V L H L H E S S G I H D I G L P Q W Q L L L C L M V V V I V L Y F S L W K G V K T S G K V V W I T A T L P Y F V L F V L L V H G V T L P G A S N G I N A Y L H I D F Y R L K E A T V W I D A A T Q I F F S L G A G F G V L I A F A S Y N K F D N N C Y R D A L L T S S I N C I T S F V S G F A I F S I L G Y M A H E H K V N I E D V A T E G A G L V F I L Y P E A I S T L S G S T F W A V V F F V M L L A L G L D S S M G G M E A V I T G L A D D F Q V L K R H R K L F T F G V T F S T F L L A L F C I T K G G I Y V L T L L D T F A A G T S I L F A V L M E A I G V S W F Y G V D R F S N D I Q Q M M G F R P G L Y W R L C W K F V S P A F L L F V V V V S I I N F K P L T Y D D Y I F P P W A N W V G W G I A L S S M V L V P I Y V I Y K F L S T Q G S L W E R L A Y G I T P E N E H H L V A Q R D I R Q F Q L Q H W L A I
PTM type	X-Acetylation X-N-glycosylation X-Oxidation X-Phosphorylation X-S-nitrosylation X: Amino Acid

Acetylation
Lysine	1 PTM Phenomena Related to This Residue		Click to Show/Hide the Full List
PTM Phenomenon 1	Have the potential to influence SLC6A2			[1]
Role of PTM	Potential impacts
Modified Residue	Lysine	Modified Location	189
Experimental Method	Co-Immunoprecipitation
Detailed Description	Acetylation at SLC6A2 Lysine 189 has the potential to affect its expression or activity.
Tyrosine	1 PTM Phenomena Related to This Residue		Click to Show/Hide the Full List
PTM Phenomenon 1	Have the potential to influence SLC6A2			[1]
Role of PTM	Potential impacts
Modified Residue	Tyrosine	Modified Location	84
Experimental Method	Co-Immunoprecipitation
Detailed Description	Acetylation at SLC6A2 Tyrosine 84 has the potential to affect its expression or activity.
N-glycosylation
Asparagine	3 PTM Phenomena Related to This Residue		Click to Show/Hide the Full List
PTM Phenomenon 1	Have the potential to influence SLC6A2			[2]
Role of PTM	Potential impacts
Modified Residue	Asparagine	Modified Location	184
Experimental Method	Co-Immunoprecipitation
Detailed Description	N-linked Glycosylation at SLC6A2 Asparagine 184 has the potential to affect its expression or activity.
PTM Phenomenon 2	Have the potential to influence SLC6A2			[2]
Role of PTM	Potential impacts
Modified Residue	Asparagine	Modified Location	192
Experimental Method	Co-Immunoprecipitation
Detailed Description	N-linked Glycosylation at SLC6A2 Asparagine 192 has the potential to affect its expression or activity.
PTM Phenomenon 3	Have the potential to influence SLC6A2			[2]
Role of PTM	Potential impacts
Modified Residue	Asparagine	Modified Location	198
Experimental Method	Co-Immunoprecipitation
Detailed Description	N-linked Glycosylation at SLC6A2 Asparagine 198 has the potential to affect its expression or activity.
Unclear Residue	1 PTM Phenomena Related to This Residue		Click to Show/Hide the Full List
PTM Phenomenon 1	No altering the apparent affinity of SLC6A2 for either substrates or inhibitors of transport but, instead, appears to influence the abundance of carriers at the cell surface			[3]
Role of PTM	Surface Expression Modulation
Studied Phenotype	Cervical cancer [ICD11: 2C77]
Experimental Material(s)	Human papillomavirus-related endocervical adenocarcinoma (HeLa) cells
Experimental Method	Co-Immunoprecipitation
Detailed Description	N-glycosylation at SLC6A2 have been reported to have no significant change in its apparent affinity for either substrates or inhibitors of transport but, instead, appears to influence the abundance at the cell surface.
Oxidation
Cystine	2 PTM Phenomena Related to This Residue		Click to Show/Hide the Full List
PTM Phenomenon 1	Have the potential to influence SLC6A2			[4]
Role of PTM	Potential impacts
Modified Residue	Cystine	Modified Location	86
Experimental Method	Co-Immunoprecipitation
Detailed Description	Oxidation at SLC6A2 Cystine 86 has the potential to affect its expression or activity.
PTM Phenomenon 2	Have the potential to influence SLC6A2			[4]
Role of PTM	Potential impacts
Modified Residue	Cystine	Modified Location	339
Experimental Method	Co-Immunoprecipitation
Detailed Description	Oxidation at SLC6A2 Cystine 339 has the potential to affect its expression or activity.
Phosphorylation
Serine	3 PTM Phenomena Related to This Residue		Click to Show/Hide the Full List
PTM Phenomenon 1	Have the potential to influence SLC6A2			[1] , [5]
Role of PTM	Potential impacts
Modified Residue	Serine	Modified Location	194
Experimental Method	Co-Immunoprecipitation
Detailed Description	Phosphorylation at SLC6A2 Serine 194 has the potential to affect its expression or activity.
PTM Phenomenon 2	Have the potential to influence SLC6A2			[5]
Role of PTM	Potential impacts
Modified Residue	Serine	Modified Location	203
Experimental Method	Co-Immunoprecipitation
Detailed Description	Phosphorylation at SLC6A2 Serine 203 has the potential to affect its expression or activity.
PTM Phenomenon 3	Have the potential to influence SLC6A2			[6]
Role of PTM	Potential impacts
Modified Residue	Serine	Modified Location	259
Experimental Method	Co-Immunoprecipitation
Detailed Description	Phosphorylation at SLC6A2 Serine 259 has the potential to affect its expression or activity.
Threonine	3 PTM Phenomena Related to This Residue		Click to Show/Hide the Full List
PTM Phenomenon 1	Increasing cell surface expression of SLC6A2			[7]
Role of PTM	Surface Expression Modulation
Affected Drug/Substrate	Norepinephrine (NE)	Results for Drug	Increasing uptake of Norepinephrine (NE)
Modified Residue	Threonine	Modified Location	30
Experimental Material(s)	Rat PFC synaptosomes
Experimental Method	Co-Immunoprecipitation
Detailed Description	Phosphorylation at SLC6A2 Threonine 30 have been reported to increase its cell surface expression.
PTM Phenomenon 2	Have the potential to influence SLC6A2			[5]
Role of PTM	Potential impacts
Modified Residue	Threonine	Modified Location	200
Experimental Method	Co-Immunoprecipitation
Detailed Description	Phosphorylation at SLC6A2 Threonine 200 has the potential to affect its expression or activity.
PTM Phenomenon 3	Have the potential to influence SLC6A2			[6]
Role of PTM	Potential impacts
Modified Residue	Threonine	Modified Location	258
Experimental Method	Co-Immunoprecipitation
Detailed Description	Phosphorylation at SLC6A2 Threonine 258 has the potential to affect its expression or activity.
Tyrosine	1 PTM Phenomena Related to This Residue		Click to Show/Hide the Full List
PTM Phenomenon 1	Have the potential to influence SLC6A2			[5]
Role of PTM	Potential impacts
Modified Residue	Tyrosine	Modified Location	202
Experimental Method	Co-Immunoprecipitation
Detailed Description	Phosphorylation at SLC6A2 Tyrosine 202 has the potential to affect its expression or activity.
S-nitrosylation
Cystine	1 PTM Phenomena Related to This Residue		Click to Show/Hide the Full List
PTM Phenomenon 1	Have the potential to influence SLC6A2			[8] , [9]
Role of PTM	Potential impacts
Modified Residue	Cystine	Modified Location	351
Experimental Method	Co-Immunoprecipitation
Detailed Description	S-nitrosylation (-SNO) at SLC6A2 Cystine 351 has the potential to affect its expression or activity.

References
1	Lys-N and trypsin cover complementary parts of the phosphoproteome in a refined SCX-based approach. Anal Chem. 2009 Jun 1;81(11):4493-501.
2	dbPTM in 2022: an updated database for exploring regulatory networks and functional associations of protein post-translational modifications. Nucleic Acids Res. 2022 Jan 7;50(D1):D471-D479. (ID: SC6A2_HUMAN)
3	N-linked oligosaccharides are required for cell surface expression of the norepinephrine transporter but do not influence substrate or inhibitor recognition. J Neurochem. 1996 Aug;67(2):645-55.
4	A Quantitative Tissue-Specific Landscape of Protein Redox Regulation during Aging. Cell. 2020 Mar 5;180(5):968-983.e24.
5	Quantitative maps of protein phosphorylation sites across 14 different rat organs and tissues. Nat Commun. 2012 Jun 6;3:876.
6	Phosphorylation of the norepinephrine transporter at threonine 258 and serine 259 is linked to protein kinase C-mediated transporter internalization. J Biol Chem. 2006 Aug 18;281(33):23326-40.
7	Cocaine up-regulation of the norepinephrine transporter requires threonine 30 phosphorylation by p38 mitogen-activated protein kinase. J Biol Chem. 2011 Jun 10;286(23):20239-50.
8	iSNO-PseAAC: predict cysteine S-nitrosylation sites in proteins by incorporating position specific amino acid propensity into pseudo amino acid composition. PLoS One. 2013;8(2):e55844.
9	dbSNO: a database of cysteine S-nitrosylation. Bioinformatics. 2012 Sep 1;28(17):2293-5.

If you find any error in data or bug in web service, please kindly report it to Dr. Yin and Dr. Li.

Detail Information of Post-Translational Modifications

Visitor Map

Correspondence